Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2538)
All Articles published online
|
Publishing Process of This Article
|
Apr 24, 2025 (publication date) through May 20, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Tsurui T, Mura E, Horiike A, Tsunoda T. Oxaliplatin-induced diffuse alveolar hemorrhage: A case report. World J Clin Oncol 2025; 16(4): 105077 [PMID: 40290687 DOI: 10.5306/wjco.v16.i4.105077] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Tsurui T, Mura E, Horiike A, Tsunoda T. Oxaliplatin-induced diffuse alveolar hemorrhage: A case report. World J Clin Oncol 2025; 16(4): 105077 [PMID: 40290687 DOI: 10.5306/wjco.v16.i4.105077] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v16/i4/105077.htm |
| Number | Citing Articles |
| 1 |
Ali Aydin, Mustafa Küpeli̇, Ahmet Karadağ. Chemosensitizing CBD/THC nanoemulsions: Functional drug-delivery carriers for synergy, dose reduction, and apoptosis in lung cancer cells. Journal of Drug Delivery Science and Technology 2026; 121: 108341 doi: 10.1016/j.jddst.2026.108341
|
| 2 |
Lucía Santa Maria de la Parra, Matías H. Assandri, Luisina M. Solernó, María de los A. Serradell, Daniel F. Alonso, Juan Garona, Lucía M. Balsa, Ignacio E. León. In Vitro and In Vivo Effects of a Copper(II)-Hydrazone Complex Against Human Osteosarcoma. Pharmaceutics 2026; 18(3): 372 doi: 10.3390/pharmaceutics18030372
|